Abstract
There is currently insufficient evidence to support the use of COX-2 inhibitors in treating chronic hepatitis or in preventing liver fibrosis.
Original language | English |
---|---|
Pages (from-to) | 903-4 |
Number of pages | 2 |
Journal | Gut |
Volume | 56 |
Issue number | 7 |
DOIs | |
Publication status | Published - 1 Jul 2007 |